Zhang Q, Zhang H, Wang S, Zeng L
Eur J Nutr. 2024; 64(1):39.
PMID: 39614876
DOI: 10.1007/s00394-024-03553-1.
Deguchi R, Komori T, Yamashita S, Hisaoka T, Kajimoto M, Kohjimoto Y
Sci Rep. 2024; 14(1):28913.
PMID: 39572752
PMC: 11582566.
DOI: 10.1038/s41598-024-80411-4.
Alathel A, Alfraidi O, Alsayyari A, Aljaafri B, Alsalamah F, Almeneif H
Urol Ann. 2024; 16(3):233-240.
PMID: 39290225
PMC: 11404719.
DOI: 10.4103/ua.ua_1_24.
Noonin C, Putpim A, Thongboonkerd V
Microbiome. 2024; 12(1):175.
PMID: 39289694
PMC: 11406782.
DOI: 10.1186/s40168-024-01877-y.
Ponugoti M, Guntupalli C, Malothu N
Urolithiasis. 2024; 52(1):127.
PMID: 39237821
DOI: 10.1007/s00240-024-01628-6.
Mendelian randomization study of urolithiasis: exploration of risk factors using human blood metabolites.
Hu D, Pan J, Deng A, Ge D, Yao R, Hou B
BMC Urol. 2024; 24(1):182.
PMID: 39198784
PMC: 11350957.
DOI: 10.1186/s12894-024-01568-8.
Association of single nucleotide genetic polymorphisms of vitamin D receptor and calcium-sensitive receptor with calcium-containing kidney stones in Chinese Dai populations: a prospective multi-center study.
Li J, Ke K, Zhang B, Liu Y, Bai J, Wang M
Int Urol Nephrol. 2024; 56(11):3647-3655.
PMID: 38886300
DOI: 10.1007/s11255-024-04109-2.
Global Trends in Kidney Stone Awareness: A Time Series Analysis from 2004-2023.
Aiumtrakul N, Thongprayoon C, Suppadungsuk S, Krisanapan P, Pinthusopon P, Mao M
Clin Pract. 2024; 14(3):915-927.
PMID: 38804404
PMC: 11130814.
DOI: 10.3390/clinpract14030072.
Prognostic Factors for Residual Lithiasis in Patients With Staghorn Calculi Undergoing Percutaneous Nephrolithotomy in the Maya Region of Yucatan, Mexico: A Case-Control Study.
Garcia-Chairez L, Franco-Gonzalez C, Gonzalez-Guillermo C, Mendez-Atoche M, Sosa-Olivares C, Cruz Nuricombo E
Cureus. 2024; 16(3):e57052.
PMID: 38681280
PMC: 11050729.
DOI: 10.7759/cureus.57052.
Analysis, treatment modality and demographic characteristics of urolithiasis patients visiting Korle-Bu Teaching Hospital in Ghana.
Akpakli E, Asante E, Kyei M, Klufio K, Toboh B, Mensah J
J West Afr Coll Surg. 2024; 14(1):94-101.
PMID: 38486658
PMC: 10936895.
DOI: 10.4103/jwas.jwas_86_23.
Management of nephrolithiasis in the Middle East over a recent decade: A systematic review.
Ahmed E
Urol Ann. 2024; 16(1):36-42.
PMID: 38415225
PMC: 10896328.
DOI: 10.4103/ua.ua_111_23.
Dysregulated palmitic acid metabolism promotes the formation of renal calcium-oxalate stones through ferroptosis induced by polyunsaturated fatty acids/phosphatidic acid.
Wang R, Zhang J, Ren H, Qi S, Xie L, Xie H
Cell Mol Life Sci. 2024; 81(1):85.
PMID: 38345762
PMC: 10861707.
DOI: 10.1007/s00018-024-05145-y.
Urolithiasis Problems in Finishing Pigs.
Vrielinck J, Janssens G, Chantziaras I, Cools A, Maes D
Vet Sci. 2023; 10(12).
PMID: 38133239
PMC: 10748364.
DOI: 10.3390/vetsci10120688.
Effect of external physical vibration lithecbole in obese patients with lower pole stones <15 mm after ESWL: a single-centre, randomized, open label clinical trial.
Li Y, Lv J
Front Med (Lausanne). 2023; 10:1101811.
PMID: 37711736
PMC: 10498918.
DOI: 10.3389/fmed.2023.1101811.
Prevalence of osteoporosis in patients with nephrolithiasis and : a cumulative analysis.
Jia S, Liao J, Wang Y, Zheng W, Jin J, Xu W
Front Endocrinol (Lausanne). 2023; 14:1180183.
PMID: 37469974
PMC: 10352837.
DOI: 10.3389/fendo.2023.1180183.
Relationship between Serum Selenium Level and Self-Reported History of Kidney Stone.
Wang A, Wang N, Zhang D, Wen J, Wang W
Nutrients. 2023; 15(11).
PMID: 37299511
PMC: 10255404.
DOI: 10.3390/nu15112549.
Tight junction and kidney stone disease.
Rungrasameviriya P, Santilinon A, Atichartsintop P, Hadpech S, Thongboonkerd V
Tissue Barriers. 2023; 12(1):2210051.
PMID: 37162265
PMC: 10832927.
DOI: 10.1080/21688370.2023.2210051.
Ghrelin and Leptin among Patients with Urolithiasis with Concomitant Hyperuricemia and Metabolic Syndrome.
Lubawy M, Blacha A, Nowicki M, Deja T, Walkowski K, Formanowicz D
Biomedicines. 2023; 11(2).
PMID: 36830821
PMC: 9953092.
DOI: 10.3390/biomedicines11020285.
Identification of the core genes in Randall's plaque of kidney stone and immune infiltration with WGCNA network.
Yu L, Li G, Jin S, Su J, Li S
Front Genet. 2023; 14:1048919.
PMID: 36816033
PMC: 9931196.
DOI: 10.3389/fgene.2023.1048919.
Prevalence and risk factors of kidney stone disease in population aged 40-70 years old in Kharameh cohort study: a cross-sectional population-based study in southern Iran.
Moftakhar L, Jafari F, Ghoddusi Johari M, Rezaeianzadeh R, Hosseini S, Rezaianzadeh A
BMC Urol. 2022; 22(1):205.
PMID: 36536352
PMC: 9764470.
DOI: 10.1186/s12894-022-01161-x.